Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders

Abstract

Rizatriptan 10-mg ODT was superior to placebo at providing two-hour pain relief and two-hour pain freedom in the treatment of acute migraine in those who do not respond to sumatriptan 100 mg. Rizatriptan was generally well tolerated in this population.